COVID-19肺炎患者死亡预测因素研究的商榷
该文针对Du等发表于《欧洲呼吸杂志》的前瞻性队列研究提出商榷,该研究在单中心纳入COVID-19肺炎患者,报告年龄≥65岁、合并心脑血管疾病、CD3+CD8+T细胞≤75 cells·μL−1及心肌肌钙蛋白I≥0.05 ng·mL−1与死亡风险增加相关,并认为后两者可作为死亡预测因素,但原文指出若干问题需澄清。
要点
- 年龄≥65岁、合并心脑血管疾病与COVID-19肺炎死亡风险增加相关。
- CD3+CD8+T细胞≤75 cells·μL−1和心肌肌钙蛋白I≥0.05 ng·mL−1被报告为死亡预测因素。
- 原文对上述预测因素研究提出若干问题需澄清。
核心结论
- 原文认为Du等关于COVID-19肺炎死亡预测因素的研究存在若干需澄清的问题。
研究设计与样本
- 原文为对Du等单中心前瞻性队列研究的商榷信。
- Du等研究采用匹配病例对照研究识别死亡预测因素。
主要发现
- Du等报告年龄≥65岁、合并心脑血管疾病、CD3+CD8+T细胞≤75 cells·μL−1及心肌肌钙蛋白I≥0.05 ng·mL−1与COVID-19肺炎死亡风险增加相关。
- Du等认为CD3+CD8+T细胞≤75 cells·μL−1和心肌肌钙蛋白I≥0.05 ng·mL−1可作为死亡预测因素。
局限性
- 原文指出Du等研究存在若干需澄清的问题,但未在摘要中具体说明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There are several issues which are worth clarifying in the paper “Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study” published in the European Respiratory Journal https://bit.ly/336rv2Y As an emerging infectious disease, coronavirus disease 2019 (COVID-19) pneumonia, which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a severe global public health emergency. According to the World Health Organization (WHO) COVID-19 epidemic interactive dashboard, as of 19 June 2020, there have been 8 385 440 confirmed cases all over the world, including 450 686 deaths. Under such urgent conditions, it is of great clinical significance to distinguish patients with poor clinical outcome (such as severe, critical or death) from within the large number of patients with COVID-19 using regular parameters (such as demographic data, past health history, and common laboratory examination results). Du et al. [1] performed a single centre prospective cohort study to investigate the possible risk factors associated with the poorest clinical outcome (dying from COVID-19 pneumonia). They reported that age ≥65 years, pre-existing concurrent cardiovascular or cerebrovascular diseases, CD3+CD8+ T-cells ≤75 cells·μL−1 and cardiac troponin I ≥0.05 ng·mL−1 in patients with COVID-19 pneumonia were associated with increased risk of death from this disease [1]. They further identified that CD3+CD8+ T-cells ≤75 cells·μL−1 and cardiac troponin I especially ≥0.05 ng·mL−1 could be used as predictors for mortality of patients with COVID-19 pneumonia using a matched case–control study [1]. With great interest, we have read the full text of the paper and found that there are several issues which are worth clarifying.
引用
- Yang HJ, Zhang YM, Yang M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2. Eur Respir J. 2020. PMID: 32747392. doi:10.1183/13993003.02439-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。